Through
4/26
A study published this week in the Journal of Neuroscience shows that the compound epothilone D (EpoD) is effective in preventing further neurological damage and improving cognitive performance in a mouse model of Alzheimer's disease (AD). The results establish how the drug might be used in early-stage AD patients.
PHILADELPHIA -- More than 90 percent of humans have antibodies to the Epstein Barr virus. Best known for causing mononucleosis, or “the kissing disease,” the virus has also been implicated in more serious conditions, including Hodgkin’s, non-Hodgkin’s and Burkitt’s lymphomas.
PHILADELPHIA ― Mayo Clinic and partners from the University of Pennsylvania School of Veterinary Medicine, the University of Minnesota College of Veterinary Medicine and College of Pharmacy, the Perelman School of Medicine at the University of Pennsylvania, and NeuroVista Corporation have been awarded $7.5 million grant (U01) from the National
Aggressive treatment for severe traumatic brain injuries costs more than routine care, yet yields significantly better outcomes, improved quality of life, and lower long term care costs, according to a new study by researchers in the Perelman School of Medicine at the University of Pennsylvania.
Only about 75 percent of HIV/AIDS patients in the United States remain in care consistently, according to new research from the Perelman School of Medicine at the University of Pennsylvania published online this week in AIDS.
Researchers from the Perelman School of Medicine at the University of Pennsylvania report this month in Cancer Research a universal approach to personalized cancer therapy based on T cells.
Aging does not appear to be a factor in poor sleep, a new study by Perelman School of Medicine at the University of Pennsylvania shows. In fact, subjective sleep quality seems to improve over a lifetime, with the fewest complaints coming from people in their 80s.
Researchers at the Perelman School of Medicine at the University of Pennsylvania have put sleeplessness on the map — literally.
Blocking autophagy -- the process of "self-eating" within cells -- is turning out to be a viable way to enhance the effectiveness of a wide variety of cancer treatments.
Injecting epilepsy patients with medication via an autoinjector -- similar to the EpiPens used to treat serious allergic reactions -- works more quickly to stop seizures than delivery of a drug via IV on board ambulances, according to a national study published today in the New England Journal of Medicine.
According to Aditi Vasan of the Leonard Davis Institute and Perelman School of Medicine, evidence is mounting in favor of the model of training community health workers to help their neighbors connect to government and health care services.
FULL STORY →
According to Thomas Wadden of the Perelman School of Medicine, people taking GLP-1 drugs are finding that daily experiences that used to trigger a compulsion to eat or think about food no longer have that effect.
FULL STORY →
PIK Professor Ezekiel Emanuel says that incessantly preparing for old age mistakes a long life for a worthwhile one.
FULL STORY →
Shoshana Aronowitz of the School of Nursing and Ashish Thakrar of the Perelman School of Medicine comment on the lack of specificity in Philadelphia’s plan to remove drug users from Kensington and on the current state of drug treatment in the city.
FULL STORY →
The Hospital of the University of Pennsylvania has been named one of the most recommended acute-care facilities by patients in the Philadelphia area.
FULL STORY →